China Pharma Holdings (CPHI) Cash & Equivalents Growth (5y) (2015 - 2026)
China Pharma Holdings (CPHI) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 32.51 Mn | 32.35 Mn | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.62% |
| Dec 31, 2025 | -18.46% |
| Sep 30, 2025 | -5.23% |
| Jun 30, 2025 | -19.19% |
| Mar 31, 2025 | 23.11% |
| Dec 31, 2024 | -10.22% |
| Sep 30, 2024 | -1.15% |
| Jun 30, 2024 | -14.89% |
| Mar 31, 2024 | -2.69% |
| Dec 31, 2023 | 207.61% |
| Sep 30, 2023 | 15.46% |
| Jun 30, 2023 | -14.16% |
| Mar 31, 2023 | -13.91% |
| Dec 31, 2022 | 92.04% |
| Sep 30, 2022 | 13.31% |
| Jun 30, 2022 | 4.74% |
| Mar 31, 2022 | 8.04% |
| Dec 31, 2021 | 12.76% |
| Sep 30, 2021 | -32.81% |
| Jun 30, 2021 | -22.13% |